Search
Browse
Statistics
Feeds

Mandatory national clinical audits as a tool to drive improvements in multiple sclerosis outcomes

[thumbnail of Publisher's Version]
Preview
PDF (Publisher's Version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB
[thumbnail of Supplementary Materials] MS Word (Supplementary Materials)
42kB

Item Type:Review
Title:Mandatory national clinical audits as a tool to drive improvements in multiple sclerosis outcomes
Creators: Giovannoni, Gavin ORCID logoORCID: https://orcid.org/0000-0001-9995-1700, Zaratin, Paola, Samadzadeh, Sara ORCID logoORCID: https://orcid.org/0000-0003-3593-1852, Drulovic, Jelena ORCID logoORCID: https://orcid.org/0000-0002-4516-3458, Thomas, Laura, Stross, Ruth, Helme, Anne ORCID logoORCID: https://orcid.org/0000-0001-8880-2347, Reyes, Saúl ORCID logoORCID: https://orcid.org/0000-0002-3230-3263, Ziemssen, Tjalf ORCID logoORCID: https://orcid.org/0000-0001-8799-8202 and Hobart, Jeremy
Abstract:Multiple sclerosis (MS) is a complex, time-critical neuroinflammatory condition where diagnostic delays and suboptimal treatment lead to irreversible disability. Despite an international consensus on best practices, equitable access to specialist care remains highly variable. We explore how implementing mandatory, continuous national clinical audit can potentially eradicate unwarranted clinical variation, drive systemic policy reform, secure targeted investment in specialist MS services, and create a positive feedback loop over time as services evolve. Drawing upon the highly successful models in stroke and cancer, we demonstrate how continuous, prospective data collection functions as an agent of change. We apply these mechanisms to MS care, using the internationally endorsed MS Brain Health: Time Matters policy recommendations, consensus quality standards, and their associated Quality Improvement tool as a blueprint for a potential mandatory national audit. Other recent initiatives, such as the Norwegian MS Registry, German implementation surveys and the UK MS Trust’s Generating Evidence in MS Services (GEMSS) programme, provide proof of concept that standardised measurement improves operational efficiency, reduces non-elective emergency admissions, and generates robust health economic data necessary for strategic MS-related healthcare commissioning. To ensure equitable, cost- effective care and unlock funding for multidisciplinary teams, healthcare systems should be encouraged to invest in the infrastructure required for mandatory, continuous national audits of MS and other brain health conditions.
Keywords:Multiple Sclerosis, Brain Health, National Audit, Quality Standard, Quality Improvement Tool
Source:Multiple Sclerosis and Related Disorders
ISSN:2211-0348
Publisher:Elsevier
Volume:116
Page Range:108033
Date:December 2026
Official Publication:https://doi.org/10.1016/j.msard.2026.108033
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library